Cite
Yuan D, Li G, Yu L, et al. CS2164 and Venetoclax Show Synergistic Antitumoral Activities in High Grade B-Cell Lymphomas With . Front Oncol. 2021;11:618908doi: 10.3389/fonc.2021.618908.
Yuan, D., Li, G., Yu, L., Jiang, Y., Shi, Y., Chen, Q., Ma, X., Pham, L. V., Young, K. H., Deng, M., Fang, Z., & Xu, B. (2021). CS2164 and Venetoclax Show Synergistic Antitumoral Activities in High Grade B-Cell Lymphomas With . Frontiers in oncology, 11618908. https://doi.org/10.3389/fonc.2021.618908
Yuan, Delin, et al. "CS2164 and Venetoclax Show Synergistic Antitumoral Activities in High Grade B-Cell Lymphomas With ." Frontiers in oncology vol. 11 (2021): 618908. doi: https://doi.org/10.3389/fonc.2021.618908
Yuan D, Li G, Yu L, Jiang Y, Shi Y, Chen Q, Ma X, Pham LV, Young KH, Deng M, Fang Z, Xu B. CS2164 and Venetoclax Show Synergistic Antitumoral Activities in High Grade B-Cell Lymphomas With . Front Oncol. 2021 Mar 10;11:618908. doi: 10.3389/fonc.2021.618908. eCollection 2021. PMID: 33777762; PMCID: PMC7988232.
Copy
Download .nbib